Nuts, metabolic syndrome and diabetes

Area of Science:

• Nutritional Science
• Cardiovascular Health
• Metabolic Health

Background:

• Nuts are known to improve blood lipid profiles and reduce coronary heart disease (CHD) risk.
• Recent interest focuses on nuts' benefits for metabolic syndrome and diabetes prevention/control.
• Cohort studies link nut consumption to reduced risk of diabetes and cardiovascular disease (CVD).

Purpose of the Study:

• To assess the effects of nuts on diabetes control, particularly glycaemic control.
• To evaluate the impact of nuts on postprandial glycaemia.
• To determine if nuts warrant inclusion in diets for individuals with diabetes and metabolic syndrome.

Main Methods:

• Review of existing cohort studies and randomised controlled trials (RCTs) on nut consumption and health outcomes.
• Analysis of acute feeding studies examining the effects of nuts on postprandial blood glucose levels.
• Evaluation of the nutritional profile of nuts, including fatty acids, protein, fiber, vitamins, and minerals.

Main Results:

• RCTs show nuts improve blood lipids but not long-term glycaemic control in diabetes.
• Acute studies indicate nuts have minimal impact on blood glucose alone but reduce postprandial glycaemic response when consumed with high-glycaemic index carbohydrates.
• Nuts possess a healthy nutritional profile beneficial for overall diet quality.

Conclusions:

• While long-term glycaemic control benefits require further research, early data suggest nuts are beneficial for individuals with diabetes and metabolic syndrome.
• Nuts' potential to reduce CHD risk supports their inclusion in dietary recommendations for these populations.
• Incorporating nuts may improve overall nutritional quality and aid in managing metabolic health conditions.